Delta Life Science joins the LSX Investival Showcase 2026 in London
Delta Life Science joins the LSX Investival Showcase in London on 16 November. Book a meeting with our team.
The LSX Investival Showcase takes place on 16 November in London, on the first day of London Life Science Week, bringing over 1,000 life science leaders and more than 150 companies together for partnering and company presentations. Two thirds of attending investors are venture capital, with interest spanning biotech, deeptech and techbio. Delta Life Science will be among them.
Techbio investors are increasingly looking past the therapeutic asset to the instrumentation underneath it. Better measurement compounds. It shortens discovery cycles, reduces failed candidates, and produces data packages that survive partner diligence.
You might have heard of surface plasmon resonance. But do you know about nanophotonic evanescent field sensing? inQuiQ brings photonics technology to label-free biosensing, and it is the foundation of what we are building at Delta Life Science.
Our SPR biosensor alternative is already in use across academic labs and biotech. The inQuiQ platform and the higher throughput inQuiQ 768 share a single photonic architecture, allowing users to scale throughput without moving to a another platform.
If you are at Old Billingsgate on 16 November and want to talk about where photonic biosensing goes next, we would like to meet.
